6821 logo

Asymchem Laboratories (Tianjin) SHSC:6821 Stock Report

Last Price

HK$57.40

Market Cap

HK$29.6b

7D

7.9%

1Y

-17.7%

Updated

15 Mar, 2025

Data

Company Financials +

Asymchem Laboratories (Tianjin) Co., Ltd.

SHSC:6821 Stock Report

Market Cap: HK$29.6b

6821 Stock Overview

Asymchem Laboratories (Tianjin) Co., Ltd. More details

6821 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth4/6
Past Performance2/6
Financial Health6/6
Dividends1/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Asymchem Laboratories (Tianjin) Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Asymchem Laboratories (Tianjin)
Historical stock prices
Current Share PriceCN¥57.40
52 Week HighCN¥74.50
52 Week LowCN¥37.60
Beta0.26
1 Month Change8.82%
3 Month Change8.71%
1 Year Change-17.71%
3 Year Change-65.51%
5 Year Changen/a
Change since IPO-72.72%

Recent News & Updates

Recent updates

Shareholder Returns

6821HK PharmaceuticalsHK Market
7D7.9%2.6%0.6%
1Y-17.7%2.2%29.0%

Return vs Industry: 6821 underperformed the Hong Kong Pharmaceuticals industry which returned 2.2% over the past year.

Return vs Market: 6821 underperformed the Hong Kong Market which returned 29% over the past year.

Price Volatility

Is 6821's price volatile compared to industry and market?
6821 volatility
6821 Average Weekly Movement6.1%
Pharmaceuticals Industry Average Movement5.3%
Market Average Movement6.9%
10% most volatile stocks in HK Market14.3%
10% least volatile stocks in HK Market3.2%

Stable Share Price: 6821 has not had significant price volatility in the past 3 months compared to the Hong Kong market.

Volatility Over Time: 6821's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19989,300Hao Hongwww.asymchem.com.cn

Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers process development and optimization, analytical, and scale-up services for small molecule drug products throughout the pre-clinical and clinical stage; and ton-scale manufacturing services for registered starting materials, advanced intermediates, and active pharmaceutical ingredients. It also engages in pre-formulation and formulation development; provision of chemical macromolecule contract development manufacture organization (CDMO) solutions for polypeptides, oligonucleotides, glycans, toxins-linkers and other macromolecules; biosynthesis solutions; biologics CDMO solutions for monoclonal antibodies and antibody-drug conjugates; and contract research organization solutions and messenger RNA solutions.

Asymchem Laboratories (Tianjin) Co., Ltd. Fundamentals Summary

How do Asymchem Laboratories (Tianjin)'s earnings and revenue compare to its market cap?
6821 fundamental statistics
Market capHK$29.55b
Earnings (TTM)HK$825.90m
Revenue (TTM)HK$5.98b

36.7x

P/E Ratio

5.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6821 income statement (TTM)
RevenueCN¥5.57b
Cost of RevenueCN¥3.24b
Gross ProfitCN¥2.33b
Other ExpensesCN¥1.56b
EarningsCN¥769.03m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Mar 28, 2025

Earnings per share (EPS)2.17
Gross Margin41.86%
Net Profit Margin13.80%
Debt/Equity Ratio0%

How did 6821 perform over the long term?

See historical performance and comparison

Dividends

2.3%

Current Dividend Yield

83%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/15 06:08
End of Day Share Price 2025/03/14 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Asymchem Laboratories (Tianjin) Co., Ltd. is covered by 27 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bo LiBofA Global Research
Yue GaoChangjiang Securities Co. LTD.
Hao WuChasing Securities